Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Physicians | 37 | 2023 | 4567 | 4.490 |
Why?
|
Malpractice | 10 | 2017 | 572 | 3.000 |
Why?
|
Insurance, Liability | 7 | 2017 | 102 | 2.900 |
Why?
|
Wounds, Gunshot | 6 | 2022 | 563 | 2.540 |
Why?
|
Schools, Medical | 8 | 2022 | 880 | 2.360 |
Why?
|
Firearms | 6 | 2023 | 598 | 2.330 |
Why?
|
Personnel Staffing and Scheduling | 8 | 2021 | 501 | 2.290 |
Why?
|
United States | 143 | 2024 | 69872 | 2.120 |
Why?
|
Drug Prescriptions | 12 | 2022 | 1637 | 2.120 |
Why?
|
Hospital Mortality | 21 | 2022 | 5317 | 2.040 |
Why?
|
Authorship | 5 | 2023 | 271 | 2.000 |
Why?
|
Medicare | 46 | 2023 | 6566 | 1.920 |
Why?
|
Analgesics, Opioid | 16 | 2022 | 3674 | 1.840 |
Why?
|
Physicians, Women | 9 | 2021 | 486 | 1.820 |
Why?
|
Health Care Costs | 12 | 2022 | 3209 | 1.800 |
Why?
|
Fraud | 4 | 2021 | 67 | 1.670 |
Why?
|
Workload | 8 | 2018 | 850 | 1.660 |
Why?
|
Family Characteristics | 4 | 2021 | 1000 | 1.630 |
Why?
|
Quality of Health Care | 13 | 2021 | 4371 | 1.630 |
Why?
|
Congresses as Topic | 4 | 2018 | 764 | 1.630 |
Why?
|
Income | 10 | 2021 | 1913 | 1.630 |
Why?
|
Carbon Monoxide Poisoning | 2 | 2022 | 66 | 1.610 |
Why?
|
Hospitalists | 6 | 2023 | 305 | 1.490 |
Why?
|
Medicine | 7 | 2021 | 946 | 1.450 |
Why?
|
Hospitals | 15 | 2023 | 3952 | 1.370 |
Why?
|
Health Personnel | 7 | 2021 | 3218 | 1.370 |
Why?
|
Faculty, Medical | 4 | 2019 | 1181 | 1.310 |
Why?
|
Hospital Costs | 6 | 2017 | 985 | 1.260 |
Why?
|
Drug Utilization | 6 | 2022 | 1183 | 1.220 |
Why?
|
Cultural Diversity | 2 | 2021 | 359 | 1.210 |
Why?
|
Liability, Legal | 4 | 2021 | 213 | 1.190 |
Why?
|
Humans | 225 | 2024 | 744343 | 1.160 |
Why?
|
Fee-for-Service Plans | 10 | 2021 | 694 | 1.140 |
Why?
|
Patient Readmission | 13 | 2022 | 3114 | 1.100 |
Why?
|
Marriage | 2 | 2018 | 339 | 1.100 |
Why?
|
Physicians, Primary Care | 4 | 2023 | 591 | 1.070 |
Why?
|
Foreign Medical Graduates | 4 | 2021 | 79 | 1.060 |
Why?
|
Hospitals, Teaching | 5 | 2018 | 1179 | 1.060 |
Why?
|
Hospitalization | 17 | 2023 | 10262 | 1.050 |
Why?
|
Health Services Research | 7 | 2021 | 1836 | 1.040 |
Why?
|
Sex Distribution | 5 | 2020 | 2297 | 1.000 |
Why?
|
Influenza Vaccines | 2 | 2024 | 738 | 0.990 |
Why?
|
Electric Power Supplies | 2 | 2022 | 99 | 0.980 |
Why?
|
Cost-Benefit Analysis | 16 | 2022 | 5391 | 0.980 |
Why?
|
Social Responsibility | 3 | 2023 | 389 | 0.950 |
Why?
|
Physician's Role | 5 | 2014 | 943 | 0.920 |
Why?
|
Emergency Service, Hospital | 15 | 2023 | 7659 | 0.900 |
Why?
|
Minoxidil | 1 | 2023 | 33 | 0.900 |
Why?
|
Drug Costs | 4 | 2019 | 1105 | 0.890 |
Why?
|
Divorce | 2 | 2015 | 79 | 0.890 |
Why?
|
Internship and Residency | 10 | 2019 | 5788 | 0.890 |
Why?
|
Mortality | 4 | 2018 | 2864 | 0.880 |
Why?
|
Students | 4 | 2022 | 1654 | 0.880 |
Why?
|
Male | 113 | 2023 | 350118 | 0.880 |
Why?
|
Censuses | 3 | 2021 | 200 | 0.870 |
Why?
|
Biomedical Technology | 3 | 2012 | 220 | 0.860 |
Why?
|
Opioid-Related Disorders | 4 | 2022 | 2065 | 0.850 |
Why?
|
Football | 2 | 2018 | 460 | 0.850 |
Why?
|
Female | 114 | 2024 | 380194 | 0.840 |
Why?
|
Public Policy | 4 | 2022 | 572 | 0.840 |
Why?
|
Internal Medicine | 3 | 2017 | 1009 | 0.810 |
Why?
|
Inpatients | 8 | 2021 | 2518 | 0.810 |
Why?
|
Leadership | 4 | 2019 | 1357 | 0.800 |
Why?
|
Observation | 2 | 2013 | 312 | 0.780 |
Why?
|
Models, Economic | 4 | 2020 | 713 | 0.770 |
Why?
|
Politics | 3 | 2022 | 791 | 0.760 |
Why?
|
Influenza, Human | 2 | 2024 | 1479 | 0.760 |
Why?
|
Social Values | 3 | 2020 | 224 | 0.760 |
Why?
|
Violence | 3 | 2023 | 909 | 0.760 |
Why?
|
Health Expenditures | 10 | 2022 | 2348 | 0.760 |
Why?
|
Sex Factors | 13 | 2021 | 10397 | 0.760 |
Why?
|
Vaccination | 3 | 2024 | 3278 | 0.760 |
Why?
|
Delivery of Health Care | 8 | 2021 | 5319 | 0.740 |
Why?
|
Endpoint Determination | 2 | 2013 | 601 | 0.720 |
Why?
|
Heart Arrest | 5 | 2017 | 1470 | 0.710 |
Why?
|
Pneumonia, Bacterial | 2 | 2013 | 316 | 0.710 |
Why?
|
Reimbursement, Incentive | 3 | 2017 | 540 | 0.700 |
Why?
|
Health Occupations | 1 | 2021 | 224 | 0.700 |
Why?
|
Medicare Part D | 3 | 2017 | 328 | 0.700 |
Why?
|
Cardiology | 4 | 2017 | 1668 | 0.700 |
Why?
|
Quality Assurance, Health Care | 4 | 2019 | 2212 | 0.700 |
Why?
|
Health Policy | 6 | 2021 | 2661 | 0.690 |
Why?
|
Retrospective Studies | 43 | 2023 | 77449 | 0.690 |
Why?
|
Group Practice | 1 | 2020 | 149 | 0.690 |
Why?
|
Foreign Professional Personnel | 1 | 2018 | 9 | 0.680 |
Why?
|
Technology Assessment, Biomedical | 3 | 2022 | 306 | 0.680 |
Why?
|
Weather | 1 | 2020 | 228 | 0.680 |
Why?
|
Hepatitis C, Chronic | 2 | 2019 | 1031 | 0.680 |
Why?
|
Golf | 1 | 2018 | 16 | 0.680 |
Why?
|
Alopecia | 1 | 2023 | 382 | 0.670 |
Why?
|
Epidemics | 2 | 2022 | 523 | 0.670 |
Why?
|
Aged | 70 | 2023 | 163280 | 0.670 |
Why?
|
Nurse Anesthetists | 1 | 2018 | 18 | 0.660 |
Why?
|
Mass Casualty Incidents | 1 | 2021 | 183 | 0.660 |
Why?
|
Peer Review, Research | 1 | 2022 | 329 | 0.650 |
Why?
|
Cross-Sectional Studies | 22 | 2023 | 25043 | 0.640 |
Why?
|
Professional Misconduct | 1 | 2018 | 73 | 0.640 |
Why?
|
Inappropriate Prescribing | 5 | 2022 | 202 | 0.640 |
Why?
|
Compensation and Redress | 2 | 2017 | 71 | 0.630 |
Why?
|
Long-Term Care | 1 | 2022 | 607 | 0.620 |
Why?
|
Rain | 1 | 2017 | 61 | 0.620 |
Why?
|
Proton Pump Inhibitors | 2 | 2013 | 526 | 0.620 |
Why?
|
Contract Services | 1 | 2017 | 94 | 0.610 |
Why?
|
Hypolipidemic Agents | 3 | 2021 | 604 | 0.610 |
Why?
|
Prescription Fees | 2 | 2016 | 146 | 0.600 |
Why?
|
Staff Development | 1 | 2019 | 223 | 0.600 |
Why?
|
Publications | 2 | 2021 | 195 | 0.600 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2021 | 3047 | 0.600 |
Why?
|
Tissue and Organ Procurement | 2 | 2023 | 896 | 0.590 |
Why?
|
Child Care | 1 | 2018 | 119 | 0.590 |
Why?
|
Biopharmaceutics | 1 | 2016 | 22 | 0.580 |
Why?
|
Telemedicine | 4 | 2022 | 2872 | 0.580 |
Why?
|
Sexually Transmitted Diseases | 2 | 2015 | 624 | 0.580 |
Why?
|
Patient Discharge | 5 | 2022 | 3313 | 0.580 |
Why?
|
Women, Working | 1 | 2017 | 87 | 0.570 |
Why?
|
Salaries and Fringe Benefits | 2 | 2016 | 264 | 0.570 |
Why?
|
Transplants | 1 | 2019 | 209 | 0.570 |
Why?
|
Policy Making | 2 | 2017 | 554 | 0.570 |
Why?
|
Causality | 2 | 2013 | 1275 | 0.550 |
Why?
|
Transportation of Patients | 1 | 2017 | 185 | 0.540 |
Why?
|
Insurance Claim Review | 6 | 2021 | 720 | 0.540 |
Why?
|
Conflict of Interest | 1 | 2021 | 544 | 0.540 |
Why?
|
Disasters | 1 | 2022 | 511 | 0.540 |
Why?
|
Cardiology Service, Hospital | 1 | 2018 | 246 | 0.540 |
Why?
|
Bibliometrics | 3 | 2021 | 339 | 0.540 |
Why?
|
Chlorofluorocarbons | 1 | 2015 | 12 | 0.540 |
Why?
|
Specialization | 5 | 2021 | 777 | 0.530 |
Why?
|
Aging, Premature | 1 | 2015 | 47 | 0.530 |
Why?
|
Famous Persons | 1 | 2016 | 108 | 0.530 |
Why?
|
Prescription Drugs | 3 | 2015 | 595 | 0.520 |
Why?
|
Preventive Health Services | 1 | 2020 | 575 | 0.510 |
Why?
|
Aged, 80 and over | 32 | 2021 | 57776 | 0.500 |
Why?
|
Publishing | 2 | 2019 | 833 | 0.500 |
Why?
|
Government | 1 | 2015 | 165 | 0.500 |
Why?
|
Nebulizers and Vaporizers | 1 | 2015 | 139 | 0.490 |
Why?
|
Automobile Driving | 1 | 2019 | 431 | 0.490 |
Why?
|
Middle Aged | 49 | 2023 | 213383 | 0.490 |
Why?
|
Emigration and Immigration | 1 | 2017 | 404 | 0.490 |
Why?
|
Accident Prevention | 1 | 2014 | 78 | 0.490 |
Why?
|
Health Plan Implementation | 2 | 2021 | 352 | 0.490 |
Why?
|
Albuterol | 1 | 2015 | 208 | 0.490 |
Why?
|
Career Choice | 1 | 2020 | 744 | 0.490 |
Why?
|
Accreditation | 1 | 2017 | 450 | 0.480 |
Why?
|
Postoperative Complications | 6 | 2022 | 15295 | 0.470 |
Why?
|
Anemia, Sickle Cell | 1 | 2022 | 1018 | 0.470 |
Why?
|
Cost of Illness | 3 | 2020 | 1859 | 0.470 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2016 | 648 | 0.460 |
Why?
|
Back Pain | 1 | 2017 | 545 | 0.460 |
Why?
|
Drug Approval | 3 | 2019 | 742 | 0.460 |
Why?
|
Arthralgia | 1 | 2017 | 456 | 0.460 |
Why?
|
Quality Improvement | 2 | 2021 | 3749 | 0.460 |
Why?
|
Age Factors | 9 | 2018 | 18370 | 0.460 |
Why?
|
Insurance Claim Reporting | 1 | 2014 | 163 | 0.450 |
Why?
|
Adult | 41 | 2023 | 214055 | 0.450 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2019 | 3658 | 0.450 |
Why?
|
Cross Infection | 2 | 2013 | 1416 | 0.450 |
Why?
|
Life Expectancy | 3 | 2018 | 1184 | 0.450 |
Why?
|
Myocardial Infarction | 7 | 2020 | 11727 | 0.450 |
Why?
|
Career Mobility | 1 | 2015 | 262 | 0.440 |
Why?
|
Cost Sharing | 2 | 2016 | 407 | 0.440 |
Why?
|
Cystic Fibrosis | 1 | 2022 | 1177 | 0.440 |
Why?
|
Reimbursement Mechanisms | 2 | 2019 | 670 | 0.440 |
Why?
|
Tachycardia | 1 | 2015 | 619 | 0.440 |
Why?
|
Professional Role | 1 | 2015 | 306 | 0.440 |
Why?
|
Quality-Adjusted Life Years | 6 | 2022 | 1683 | 0.430 |
Why?
|
Drug Industry | 3 | 2017 | 746 | 0.430 |
Why?
|
Periodicals as Topic | 4 | 2021 | 1432 | 0.430 |
Why?
|
Organ Transplantation | 1 | 2023 | 1139 | 0.430 |
Why?
|
Seasons | 2 | 2020 | 1493 | 0.430 |
Why?
|
Advanced Cardiac Life Support | 4 | 2016 | 70 | 0.420 |
Why?
|
Epidemiologic Research Design | 1 | 2016 | 367 | 0.420 |
Why?
|
Insurance, Health | 7 | 2022 | 2494 | 0.420 |
Why?
|
Running | 1 | 2017 | 480 | 0.420 |
Why?
|
Health Care Reform | 3 | 2014 | 1261 | 0.420 |
Why?
|
Regression Analysis | 4 | 2021 | 6459 | 0.420 |
Why?
|
Advance Care Planning | 1 | 2019 | 662 | 0.420 |
Why?
|
End Stage Liver Disease | 1 | 2016 | 314 | 0.410 |
Why?
|
Heart Diseases | 2 | 2015 | 2788 | 0.410 |
Why?
|
Guideline Adherence | 5 | 2021 | 2266 | 0.410 |
Why?
|
Bronchodilator Agents | 1 | 2015 | 502 | 0.410 |
Why?
|
Negotiating | 1 | 2013 | 133 | 0.400 |
Why?
|
Safety | 2 | 2014 | 1186 | 0.400 |
Why?
|
School Admission Criteria | 1 | 2012 | 105 | 0.400 |
Why?
|
Search Engine | 1 | 2013 | 144 | 0.400 |
Why?
|
Florida | 3 | 2019 | 435 | 0.400 |
Why?
|
Emergency Medical Services | 4 | 2017 | 1917 | 0.390 |
Why?
|
Students, Medical | 2 | 2022 | 1862 | 0.390 |
Why?
|
Psychology, Industrial | 1 | 2010 | 7 | 0.390 |
Why?
|
Hyperlipidemias | 1 | 2016 | 789 | 0.390 |
Why?
|
Coronary Artery Bypass | 2 | 2020 | 2289 | 0.390 |
Why?
|
Education, Medical | 2 | 2013 | 1721 | 0.380 |
Why?
|
Mothers | 1 | 2021 | 2165 | 0.380 |
Why?
|
Economics, Hospital | 1 | 2013 | 213 | 0.380 |
Why?
|
Homicide | 1 | 2013 | 287 | 0.380 |
Why?
|
Chronic Disease | 4 | 2022 | 9146 | 0.380 |
Why?
|
Aortic Valve Stenosis | 2 | 2021 | 1965 | 0.380 |
Why?
|
Models, Econometric | 3 | 2020 | 218 | 0.370 |
Why?
|
Population Surveillance | 1 | 2021 | 2616 | 0.370 |
Why?
|
Pain | 2 | 2016 | 4986 | 0.370 |
Why?
|
Terminal Care | 2 | 2023 | 1694 | 0.370 |
Why?
|
Law Enforcement | 1 | 2011 | 109 | 0.370 |
Why?
|
Asthma | 3 | 2020 | 6011 | 0.370 |
Why?
|
Clinical Competence | 4 | 2021 | 4687 | 0.370 |
Why?
|
Pregnancy, Multiple | 1 | 2011 | 217 | 0.360 |
Why?
|
Drug Discovery | 1 | 2018 | 1058 | 0.360 |
Why?
|
Diffusion of Innovation | 4 | 2021 | 725 | 0.360 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1587 | 0.350 |
Why?
|
Length of Stay | 4 | 2017 | 6309 | 0.350 |
Why?
|
Internet | 2 | 2013 | 3064 | 0.350 |
Why?
|
Minority Groups | 3 | 2022 | 1223 | 0.350 |
Why?
|
Socioeconomic Factors | 5 | 2016 | 7785 | 0.350 |
Why?
|
Twins | 1 | 2011 | 339 | 0.350 |
Why?
|
Registries | 4 | 2023 | 8089 | 0.340 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 2020 | 0.340 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2010 | 215 | 0.340 |
Why?
|
Patient Transfer | 1 | 2016 | 761 | 0.340 |
Why?
|
Anti-Bacterial Agents | 3 | 2022 | 7181 | 0.340 |
Why?
|
Diagnostic Errors | 2 | 2017 | 1257 | 0.340 |
Why?
|
Pandemics | 6 | 2023 | 8388 | 0.340 |
Why?
|
Personnel Turnover | 2 | 2021 | 83 | 0.330 |
Why?
|
Papillomavirus Vaccines | 1 | 2015 | 491 | 0.330 |
Why?
|
Ambulances | 2 | 2021 | 95 | 0.330 |
Why?
|
Odds Ratio | 7 | 2024 | 9849 | 0.320 |
Why?
|
Antineoplastic Agents | 6 | 2019 | 13695 | 0.320 |
Why?
|
Anesthesiology | 1 | 2018 | 1060 | 0.320 |
Why?
|
Substance-Related Disorders | 3 | 2022 | 4258 | 0.320 |
Why?
|
Mastectomy | 1 | 2016 | 1793 | 0.320 |
Why?
|
Age Distribution | 4 | 2019 | 2902 | 0.310 |
Why?
|
Pre-Eclampsia | 1 | 2017 | 1200 | 0.310 |
Why?
|
Antidepressive Agents | 1 | 2020 | 2838 | 0.310 |
Why?
|
Pharmaceutical Services | 1 | 2009 | 140 | 0.310 |
Why?
|
Multivariate Analysis | 6 | 2019 | 12245 | 0.310 |
Why?
|
Epidemiologic Methods | 1 | 2013 | 1364 | 0.300 |
Why?
|
Databases, Factual | 8 | 2020 | 7729 | 0.300 |
Why?
|
Emergency Medicine | 1 | 2017 | 1207 | 0.300 |
Why?
|
Medical Errors | 1 | 2016 | 1297 | 0.300 |
Why?
|
Time Factors | 12 | 2021 | 40075 | 0.300 |
Why?
|
Hypothermia, Induced | 1 | 2012 | 752 | 0.300 |
Why?
|
Anesthesia | 1 | 2018 | 1561 | 0.300 |
Why?
|
Comparative Effectiveness Research | 4 | 2014 | 681 | 0.290 |
Why?
|
Incidence | 9 | 2021 | 20947 | 0.290 |
Why?
|
Early Detection of Cancer | 3 | 2021 | 3086 | 0.290 |
Why?
|
Electrocardiography | 1 | 2020 | 6442 | 0.290 |
Why?
|
Self Report | 2 | 2015 | 3558 | 0.290 |
Why?
|
Cholesterol, LDL | 1 | 2016 | 2356 | 0.280 |
Why?
|
Decision Support Systems, Clinical | 1 | 2016 | 1164 | 0.280 |
Why?
|
Models, Statistical | 4 | 2016 | 5102 | 0.280 |
Why?
|
Suicide | 2 | 2014 | 1477 | 0.280 |
Why?
|
Erectile Dysfunction | 1 | 2010 | 461 | 0.280 |
Why?
|
Ownership | 2 | 2021 | 332 | 0.280 |
Why?
|
Biomedical Research | 4 | 2018 | 3309 | 0.270 |
Why?
|
Atrial Fibrillation | 3 | 2021 | 5034 | 0.270 |
Why?
|
Vasodilator Agents | 1 | 2010 | 977 | 0.270 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2021 | 3255 | 0.270 |
Why?
|
Research Design | 3 | 2018 | 5987 | 0.260 |
Why?
|
Homosexuality, Male | 1 | 2013 | 1240 | 0.260 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6895 | 0.250 |
Why?
|
Liver Transplantation | 1 | 2016 | 2119 | 0.250 |
Why?
|
Blood Glucose | 1 | 2019 | 6256 | 0.250 |
Why?
|
Mammography | 1 | 2016 | 2476 | 0.250 |
Why?
|
Sulfonylurea Compounds | 2 | 2016 | 204 | 0.250 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 11524 | 0.250 |
Why?
|
Surgical Procedures, Operative | 3 | 2021 | 1876 | 0.240 |
Why?
|
Acute Coronary Syndrome | 1 | 2018 | 2337 | 0.240 |
Why?
|
Life Support Care | 2 | 2016 | 228 | 0.240 |
Why?
|
Child | 13 | 2024 | 77709 | 0.240 |
Why?
|
Logistic Models | 5 | 2017 | 13408 | 0.240 |
Why?
|
Respiratory Tract Infections | 2 | 2021 | 961 | 0.240 |
Why?
|
Life Style | 1 | 2015 | 3835 | 0.230 |
Why?
|
Osteopathic Physicians | 1 | 2023 | 2 | 0.230 |
Why?
|
Genetic Testing | 1 | 2016 | 3444 | 0.230 |
Why?
|
Health Behavior | 1 | 2015 | 2636 | 0.230 |
Why?
|
Efficiency, Organizational | 1 | 2008 | 695 | 0.230 |
Why?
|
Cohort Studies | 8 | 2024 | 40561 | 0.220 |
Why?
|
United States Food and Drug Administration | 5 | 2023 | 1584 | 0.220 |
Why?
|
Motorcycles | 1 | 2023 | 44 | 0.210 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 4644 | 0.210 |
Why?
|
Ivermectin | 1 | 2022 | 42 | 0.210 |
Why?
|
Health Services Needs and Demand | 2 | 2021 | 1411 | 0.210 |
Why?
|
Commerce | 1 | 2007 | 592 | 0.200 |
Why?
|
Communication | 2 | 2012 | 3749 | 0.200 |
Why?
|
Epoetin Alfa | 1 | 2021 | 83 | 0.200 |
Why?
|
Evidence-Based Medicine | 4 | 2020 | 3610 | 0.200 |
Why?
|
Young Adult | 8 | 2022 | 56430 | 0.200 |
Why?
|
Cardiovascular Diseases | 3 | 2017 | 15165 | 0.200 |
Why?
|
Fibric Acids | 1 | 2021 | 25 | 0.190 |
Why?
|
Educational Status | 3 | 2017 | 2540 | 0.190 |
Why?
|
Public Sector | 2 | 2016 | 265 | 0.190 |
Why?
|
Emergency Treatment | 2 | 2015 | 517 | 0.190 |
Why?
|
Holidays | 1 | 2020 | 42 | 0.190 |
Why?
|
Demography | 2 | 2016 | 1656 | 0.190 |
Why?
|
Ambulatory Care | 2 | 2022 | 2708 | 0.190 |
Why?
|
Treatment Outcome | 12 | 2021 | 63114 | 0.190 |
Why?
|
Out-of-Hospital Cardiac Arrest | 2 | 2015 | 339 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2020 | 3923 | 0.190 |
Why?
|
Survival Analysis | 6 | 2021 | 10252 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2021 | 11725 | 0.180 |
Why?
|
Marketing | 1 | 2022 | 212 | 0.180 |
Why?
|
Parturition | 1 | 2024 | 441 | 0.180 |
Why?
|
Health Services Misuse | 2 | 2019 | 243 | 0.180 |
Why?
|
Prevalence | 5 | 2016 | 15226 | 0.180 |
Why?
|
Amiodarone | 1 | 2021 | 212 | 0.180 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 12354 | 0.180 |
Why?
|
Fluoroquinolones | 1 | 2021 | 310 | 0.170 |
Why?
|
Electronic Health Records | 1 | 2016 | 4468 | 0.170 |
Why?
|
Nutrition Surveys | 2 | 2016 | 1660 | 0.170 |
Why?
|
Pediatrics | 2 | 2017 | 3475 | 0.170 |
Why?
|
Cost Control | 2 | 2014 | 624 | 0.170 |
Why?
|
Adolescent | 11 | 2022 | 85781 | 0.170 |
Why?
|
Neoplasms | 6 | 2021 | 21683 | 0.170 |
Why?
|
History, 20th Century | 2 | 2018 | 2740 | 0.170 |
Why?
|
Personnel Management | 1 | 2018 | 55 | 0.160 |
Why?
|
Risk | 4 | 2017 | 9687 | 0.160 |
Why?
|
Policy | 1 | 2022 | 508 | 0.160 |
Why?
|
Hypoglycemia | 2 | 2016 | 861 | 0.160 |
Why?
|
Prognosis | 2 | 2016 | 29063 | 0.160 |
Why?
|
HIV Infections | 3 | 2015 | 16718 | 0.160 |
Why?
|
Hydroxychloroquine | 1 | 2022 | 412 | 0.160 |
Why?
|
Sleep Medicine Specialty | 1 | 2018 | 71 | 0.160 |
Why?
|
Biological Science Disciplines | 1 | 2018 | 52 | 0.160 |
Why?
|
Sweden | 1 | 2020 | 1345 | 0.150 |
Why?
|
Fetal Distress | 1 | 2017 | 40 | 0.150 |
Why?
|
Warfarin | 2 | 2016 | 1496 | 0.150 |
Why?
|
Administration, Oral | 2 | 2023 | 3913 | 0.150 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2021 | 397 | 0.150 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2017 | 93 | 0.150 |
Why?
|
Health Status | 1 | 2010 | 4034 | 0.150 |
Why?
|
Organizations | 1 | 2018 | 170 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2018 | 9959 | 0.150 |
Why?
|
Hypogonadism | 1 | 2023 | 799 | 0.140 |
Why?
|
Cause of Death | 2 | 2018 | 3584 | 0.140 |
Why?
|
Oxycodone | 1 | 2018 | 153 | 0.140 |
Why?
|
Markov Chains | 2 | 2020 | 969 | 0.140 |
Why?
|
Pulmonary Medicine | 1 | 2018 | 213 | 0.140 |
Why?
|
Hospitals, University | 1 | 2018 | 571 | 0.140 |
Why?
|
Insurance Coverage | 3 | 2017 | 1901 | 0.140 |
Why?
|
Hospitals, Community | 1 | 2018 | 348 | 0.140 |
Why?
|
Hospice Care | 1 | 2023 | 672 | 0.140 |
Why?
|
Rural Population | 2 | 2017 | 2210 | 0.140 |
Why?
|
Medicare Part B | 1 | 2017 | 108 | 0.140 |
Why?
|
Leukomalacia, Periventricular | 1 | 2017 | 184 | 0.140 |
Why?
|
Hypoglycemic Agents | 3 | 2021 | 2872 | 0.140 |
Why?
|
Organizational Culture | 2 | 2018 | 510 | 0.140 |
Why?
|
Glipizide | 1 | 2015 | 47 | 0.140 |
Why?
|
Medicaid | 4 | 2020 | 2736 | 0.130 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2017 | 214 | 0.130 |
Why?
|
Hospitals, Proprietary | 1 | 2015 | 39 | 0.130 |
Why?
|
Papillomaviridae | 1 | 2021 | 1119 | 0.130 |
Why?
|
Health Services Accessibility | 4 | 2020 | 5137 | 0.130 |
Why?
|
Workplace | 2 | 2012 | 836 | 0.130 |
Why?
|
California | 3 | 2018 | 1402 | 0.130 |
Why?
|
Child, Preschool | 5 | 2024 | 41006 | 0.130 |
Why?
|
Patients | 1 | 2022 | 900 | 0.130 |
Why?
|
Pain, Postoperative | 2 | 2022 | 1643 | 0.130 |
Why?
|
Quality of Life | 1 | 2016 | 12804 | 0.120 |
Why?
|
Waiting Lists | 1 | 2019 | 692 | 0.120 |
Why?
|
Air Pollution, Indoor | 1 | 2022 | 857 | 0.120 |
Why?
|
Licensure | 2 | 2022 | 124 | 0.120 |
Why?
|
Mandatory Programs | 1 | 2015 | 87 | 0.120 |
Why?
|
Physical Examination | 1 | 2020 | 1237 | 0.120 |
Why?
|
Drug Combinations | 1 | 2019 | 1959 | 0.120 |
Why?
|
Pregnancy | 4 | 2024 | 29144 | 0.120 |
Why?
|
Outpatients | 2 | 2021 | 1486 | 0.120 |
Why?
|
Herpes Genitalis | 1 | 2015 | 141 | 0.120 |
Why?
|
Drug and Narcotic Control | 1 | 2015 | 146 | 0.120 |
Why?
|
Universities | 1 | 2019 | 956 | 0.120 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2017 | 306 | 0.120 |
Why?
|
Arthroplasty, Replacement, Knee | 2 | 2022 | 1458 | 0.120 |
Why?
|
Postpartum Hemorrhage | 1 | 2017 | 258 | 0.120 |
Why?
|
Exercise | 1 | 2010 | 5615 | 0.110 |
Why?
|
Genes, BRCA2 | 1 | 2016 | 618 | 0.110 |
Why?
|
Benzodiazepines | 1 | 2019 | 1101 | 0.110 |
Why?
|
Unsafe Sex | 1 | 2015 | 220 | 0.110 |
Why?
|
Tissue Donors | 1 | 2023 | 2240 | 0.110 |
Why?
|
Physician Impairment | 1 | 2013 | 73 | 0.110 |
Why?
|
Legislation as Topic | 1 | 2013 | 80 | 0.110 |
Why?
|
Genes, BRCA1 | 1 | 2016 | 781 | 0.110 |
Why?
|
Syphilis | 1 | 2015 | 227 | 0.110 |
Why?
|
Testosterone | 1 | 2023 | 2420 | 0.110 |
Why?
|
Administration, Inhalation | 1 | 2015 | 1105 | 0.110 |
Why?
|
State Medicine | 1 | 2014 | 217 | 0.110 |
Why?
|
Breast Neoplasms | 2 | 2016 | 20822 | 0.100 |
Why?
|
Risk Management | 1 | 2016 | 571 | 0.100 |
Why?
|
Physicians' Offices | 2 | 2022 | 58 | 0.100 |
Why?
|
Hypoxia, Brain | 1 | 2012 | 133 | 0.100 |
Why?
|
Urinary Tract Infections | 2 | 2021 | 788 | 0.100 |
Why?
|
Anemia | 1 | 2021 | 1506 | 0.100 |
Why?
|
Cost Savings | 1 | 2017 | 926 | 0.100 |
Why?
|
Sick Leave | 1 | 2012 | 110 | 0.100 |
Why?
|
Critical Care | 3 | 2020 | 2647 | 0.100 |
Why?
|
Chlamydia Infections | 1 | 2015 | 365 | 0.100 |
Why?
|
Costs and Cost Analysis | 2 | 2020 | 1681 | 0.100 |
Why?
|
Risk Assessment | 4 | 2021 | 23338 | 0.100 |
Why?
|
Mitral Valve Insufficiency | 1 | 2021 | 1422 | 0.100 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 840 | 0.100 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2020 | 1004 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2016 | 1184 | 0.100 |
Why?
|
Monte Carlo Method | 1 | 2016 | 1254 | 0.100 |
Why?
|
Gonorrhea | 1 | 2015 | 335 | 0.090 |
Why?
|
Anticoagulants | 2 | 2016 | 4599 | 0.090 |
Why?
|
Attitude of Health Personnel | 2 | 2018 | 3843 | 0.090 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2014 | 841 | 0.090 |
Why?
|
Risk Adjustment | 1 | 2014 | 594 | 0.090 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2021 | 1536 | 0.090 |
Why?
|
Clostridium Infections | 1 | 2017 | 548 | 0.090 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2011 | 168 | 0.090 |
Why?
|
Professional Competence | 1 | 2013 | 447 | 0.090 |
Why?
|
Financing, Government | 1 | 2014 | 468 | 0.090 |
Why?
|
Europe | 2 | 2015 | 3339 | 0.090 |
Why?
|
Emergencies | 1 | 2016 | 1170 | 0.090 |
Why?
|
Health Priorities | 1 | 2012 | 380 | 0.090 |
Why?
|
Burnout, Professional | 1 | 2018 | 694 | 0.090 |
Why?
|
Sample Size | 1 | 2013 | 845 | 0.090 |
Why?
|
Anticholesteremic Agents | 1 | 2016 | 979 | 0.090 |
Why?
|
Thrombocytopenia | 1 | 2017 | 1179 | 0.090 |
Why?
|
Economics | 1 | 2010 | 146 | 0.080 |
Why?
|
Adenoma | 1 | 2020 | 2174 | 0.080 |
Why?
|
History, 21st Century | 1 | 2015 | 1534 | 0.080 |
Why?
|
Patient Admission | 1 | 2017 | 1380 | 0.080 |
Why?
|
Work Schedule Tolerance | 1 | 2013 | 565 | 0.080 |
Why?
|
Dementia | 1 | 2023 | 2518 | 0.080 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2017 | 1209 | 0.080 |
Why?
|
Prescriptions | 2 | 2022 | 387 | 0.080 |
Why?
|
Nephrectomy | 1 | 2015 | 1050 | 0.080 |
Why?
|
Renal Insufficiency | 1 | 2015 | 804 | 0.080 |
Why?
|
Consensus | 1 | 2018 | 2959 | 0.080 |
Why?
|
Family Relations | 1 | 2011 | 321 | 0.080 |
Why?
|
Confidence Intervals | 2 | 2013 | 2971 | 0.080 |
Why?
|
Health Care Surveys | 1 | 2016 | 2453 | 0.080 |
Why?
|
Risk Factors | 7 | 2021 | 72290 | 0.080 |
Why?
|
Gestational Age | 1 | 2017 | 3493 | 0.080 |
Why?
|
Community-Acquired Infections | 1 | 2012 | 465 | 0.080 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2013 | 430 | 0.080 |
Why?
|
Marital Status | 1 | 2010 | 437 | 0.080 |
Why?
|
Mental Disorders | 2 | 2018 | 6600 | 0.080 |
Why?
|
Comorbidity | 2 | 2012 | 10388 | 0.080 |
Why?
|
Fees and Charges | 2 | 2021 | 195 | 0.080 |
Why?
|
Anti-Asthmatic Agents | 1 | 2012 | 536 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2208 | 0.070 |
Why?
|
Wounds and Injuries | 2 | 2017 | 2400 | 0.070 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2018 | 1414 | 0.070 |
Why?
|
Primary Health Care | 2 | 2021 | 4558 | 0.070 |
Why?
|
Heart Failure | 4 | 2022 | 10900 | 0.070 |
Why?
|
Medication Adherence | 1 | 2018 | 2063 | 0.070 |
Why?
|
Psychiatry | 1 | 2019 | 1695 | 0.070 |
Why?
|
Cesarean Section | 1 | 2015 | 1365 | 0.070 |
Why?
|
Observer Variation | 1 | 2013 | 2593 | 0.070 |
Why?
|
Investments | 1 | 2008 | 143 | 0.070 |
Why?
|
General Surgery | 1 | 2018 | 1636 | 0.070 |
Why?
|
Counseling | 1 | 2014 | 1523 | 0.070 |
Why?
|
Specialties, Surgical | 1 | 2011 | 391 | 0.070 |
Why?
|
Pain Measurement | 1 | 2016 | 3420 | 0.070 |
Why?
|
Program Development | 1 | 2013 | 1316 | 0.070 |
Why?
|
Health Care Sector | 1 | 2008 | 194 | 0.070 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2021 | 789 | 0.070 |
Why?
|
Fatigue | 1 | 2013 | 1531 | 0.070 |
Why?
|
Societies, Medical | 1 | 2018 | 3743 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2716 | 0.070 |
Why?
|
Guidelines as Topic | 1 | 2012 | 1405 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2016 | 1956 | 0.070 |
Why?
|
Cerebral Hemorrhage | 1 | 2017 | 2647 | 0.070 |
Why?
|
Heart | 1 | 2019 | 4467 | 0.070 |
Why?
|
Interviews as Topic | 1 | 2012 | 2539 | 0.070 |
Why?
|
Developed Countries | 1 | 2008 | 437 | 0.060 |
Why?
|
Central Nervous System Stimulants | 1 | 2014 | 1148 | 0.060 |
Why?
|
Chest Pain | 1 | 2012 | 1114 | 0.060 |
Why?
|
Pneumonia | 2 | 2014 | 2133 | 0.060 |
Why?
|
Disease Transmission, Infectious | 1 | 2010 | 547 | 0.060 |
Why?
|
Data Collection | 2 | 2012 | 3341 | 0.060 |
Why?
|
Osteoarthritis | 1 | 2012 | 1036 | 0.060 |
Why?
|
Seizures | 1 | 2017 | 2859 | 0.060 |
Why?
|
Private Sector | 1 | 2007 | 392 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2017 | 25625 | 0.060 |
Why?
|
Heart Rate | 1 | 2015 | 4091 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2017 | 3679 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2021 | 13989 | 0.060 |
Why?
|
Military Personnel | 1 | 2012 | 1133 | 0.060 |
Why?
|
Kidney | 1 | 2019 | 7186 | 0.060 |
Why?
|
Liver | 1 | 2019 | 7474 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3158 | 0.060 |
Why?
|
Sepsis | 1 | 2017 | 2593 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 7913 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2015 | 3297 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 8987 | 0.050 |
Why?
|
Linear Models | 1 | 2012 | 5952 | 0.050 |
Why?
|
Safety-Based Drug Withdrawals | 1 | 2021 | 38 | 0.050 |
Why?
|
Off-Label Use | 1 | 2023 | 169 | 0.050 |
Why?
|
Defensive Medicine | 1 | 2021 | 48 | 0.050 |
Why?
|
Patient Care Team | 1 | 2013 | 2531 | 0.050 |
Why?
|
Radiology | 1 | 2015 | 2100 | 0.050 |
Why?
|
Education, Medical, Graduate | 1 | 2013 | 2291 | 0.050 |
Why?
|
Bronchitis | 1 | 2021 | 201 | 0.050 |
Why?
|
Tuberculosis, Spinal | 1 | 2000 | 16 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14722 | 0.050 |
Why?
|
Program Evaluation | 1 | 2009 | 2488 | 0.050 |
Why?
|
Lung | 1 | 2019 | 9856 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6773 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39050 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10943 | 0.040 |
Why?
|
Patient Preference | 2 | 2020 | 890 | 0.040 |
Why?
|
Fenofibrate | 1 | 2020 | 88 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9274 | 0.040 |
Why?
|
Drug Labeling | 1 | 2021 | 233 | 0.040 |
Why?
|
Survival Rate | 1 | 2014 | 12788 | 0.040 |
Why?
|
Occult Blood | 1 | 2020 | 176 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 21746 | 0.040 |
Why?
|
Stroke | 4 | 2015 | 9981 | 0.040 |
Why?
|
Hematinics | 1 | 2021 | 281 | 0.040 |
Why?
|
Research | 1 | 2007 | 1999 | 0.040 |
Why?
|
Financing, Personal | 2 | 2012 | 308 | 0.040 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2001 | 404 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4262 | 0.040 |
Why?
|
Morphine | 1 | 2022 | 657 | 0.040 |
Why?
|
Symporters | 1 | 2001 | 362 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19905 | 0.040 |
Why?
|
Medical Oncology | 1 | 2009 | 2265 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2010 | 3589 | 0.040 |
Why?
|
Motivation | 1 | 2007 | 1971 | 0.040 |
Why?
|
Aftercare | 1 | 2022 | 866 | 0.040 |
Why?
|
Office Visits | 1 | 2021 | 598 | 0.040 |
Why?
|
Medicare Part C | 1 | 2021 | 296 | 0.030 |
Why?
|
Insurance, Pharmaceutical Services | 2 | 2009 | 336 | 0.030 |
Why?
|
Schizophrenia | 2 | 2013 | 6882 | 0.030 |
Why?
|
General Practice | 1 | 2017 | 100 | 0.030 |
Why?
|
Glyburide | 1 | 2016 | 113 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2009 | 3022 | 0.030 |
Why?
|
Postoperative Period | 1 | 2020 | 1842 | 0.030 |
Why?
|
Surgery Department, Hospital | 1 | 2017 | 175 | 0.030 |
Why?
|
Infant | 1 | 2017 | 35136 | 0.030 |
Why?
|
Hospital Records | 1 | 2015 | 95 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 2001 | 1028 | 0.030 |
Why?
|
Unnecessary Procedures | 1 | 2019 | 432 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17446 | 0.030 |
Why?
|
Craniotomy | 1 | 2019 | 729 | 0.030 |
Why?
|
Infection Control | 1 | 2021 | 966 | 0.030 |
Why?
|
Asia | 1 | 2015 | 610 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7279 | 0.030 |
Why?
|
Hip Fractures | 2 | 2013 | 955 | 0.030 |
Why?
|
Pathology, Clinical | 1 | 2017 | 368 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2015 | 336 | 0.030 |
Why?
|
Time | 1 | 2015 | 542 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2309 | 0.030 |
Why?
|
Sinusitis | 1 | 2021 | 923 | 0.030 |
Why?
|
Mitral Valve | 1 | 2021 | 1491 | 0.030 |
Why?
|
Employee Performance Appraisal | 1 | 2013 | 87 | 0.030 |
Why?
|
Hospitals, General | 1 | 2016 | 749 | 0.030 |
Why?
|
Family | 1 | 2023 | 3147 | 0.030 |
Why?
|
Colonoscopy | 1 | 2020 | 1367 | 0.030 |
Why?
|
North America | 1 | 2015 | 1249 | 0.030 |
Why?
|
Drug Interactions | 1 | 2016 | 1460 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2015 | 930 | 0.020 |
Why?
|
Internationality | 1 | 2017 | 1003 | 0.020 |
Why?
|
Health Facility Size | 1 | 2011 | 64 | 0.020 |
Why?
|
Gastroenterology | 1 | 2017 | 536 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7149 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6489 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2021 | 2585 | 0.020 |
Why?
|
Military Medicine | 1 | 2012 | 176 | 0.020 |
Why?
|
Value of Life | 1 | 2010 | 97 | 0.020 |
Why?
|
SEER Program | 1 | 2015 | 1508 | 0.020 |
Why?
|
Parents | 1 | 2023 | 3407 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2684 | 0.020 |
Why?
|
Patient Care Management | 1 | 2013 | 306 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4037 | 0.020 |
Why?
|
Antipsychotic Agents | 2 | 2013 | 3057 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1781 | 0.020 |
Why?
|
Government Programs | 1 | 2011 | 275 | 0.020 |
Why?
|
Escherichia coli | 1 | 2001 | 4217 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4933 | 0.020 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2019 | 1462 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2015 | 1199 | 0.020 |
Why?
|
Nutritional Status | 1 | 2015 | 1609 | 0.020 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2007 | 320 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6538 | 0.020 |
Why?
|
Lactones | 1 | 2007 | 329 | 0.020 |
Why?
|
Sulfones | 1 | 2007 | 437 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3229 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8663 | 0.010 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2011 | 1130 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3396 | 0.010 |
Why?
|
Mental Health | 1 | 2017 | 3019 | 0.010 |
Why?
|
Patient Participation | 1 | 2011 | 1457 | 0.010 |
Why?
|
Melibiose | 1 | 2001 | 3 | 0.010 |
Why?
|
Forecasting | 1 | 2011 | 2951 | 0.010 |
Why?
|
Galactosides | 1 | 2001 | 52 | 0.010 |
Why?
|
Cations | 1 | 2001 | 232 | 0.010 |
Why?
|
Paraplegia | 1 | 2000 | 168 | 0.010 |
Why?
|
Quadriplegia | 1 | 2000 | 223 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2001 | 1246 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1723 | 0.010 |
Why?
|
Biological Transport | 1 | 2001 | 2118 | 0.010 |
Why?
|
Mass Screening | 1 | 2010 | 5255 | 0.010 |
Why?
|
Kinetics | 1 | 2001 | 6473 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 53288 | 0.010 |
Why?
|
Models, Molecular | 1 | 2001 | 5456 | 0.010 |
Why?
|
Mutation | 1 | 2001 | 29786 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2000 | 35421 | 0.000 |
Why?
|